These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34375688)

  • 1. Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases.
    Mehta M; Paudel KR; Shukla SD; Allam VSRR; Kannaujiya VK; Panth N; Das A; Parihar VK; Chakraborty A; Ali MK; Jha NK; Xenaki D; Su QP; Wich PR; Adams J; Hansbro PM; Chellappan DK; Oliver BGG; Dua K
    J Control Release; 2021 Sep; 337():629-644. PubMed ID: 34375688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intratracheal administration of nuclear factor-kappaB decoy oligodeoxynucleotides on long-term cigarette smoke-induced lung inflammation and pathology in mice.
    Li YT; He B; Wang YZ; Wang J
    Respir Res; 2009 Aug; 10(1):79. PubMed ID: 19706153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-oxidant gene therapy by NF kappa B decoy oligodeoxynucleotide.
    Nakagami H; Tomita N; Kaneda Y; Ogihara T; Morishita R
    Curr Pharm Biotechnol; 2006 Apr; 7(2):95-100. PubMed ID: 16724943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3/NF‑κB decoy oligodeoxynucleotides inhibit atherosclerosis through regulation of the STAT/NF‑κB signaling pathway in a mouse model of atherosclerosis.
    An HJ; Gwon MG; Gu H; Bae S; Leem J; Lee JB; Park KK
    Int J Mol Med; 2023 May; 51(5):. PubMed ID: 37026512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides.
    Farahmand L; Darvishi B; Majidzadeh-A K
    Drug Deliv; 2017 Nov; 24(1):1249-1261. PubMed ID: 28870118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the therapeutic efficacy of NFκB synthetic decoy oligodeoxynucleotides (ODNs).
    Wang Z; Potoyan DA; Wolynes PG
    BMC Syst Biol; 2018 Jan; 12(1):4. PubMed ID: 29382384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratracheally instilled mannosylated cationic liposome/NFκB decoy complexes for effective prevention of LPS-induced lung inflammation.
    Wijagkanalan W; Kawakami S; Higuchi Y; Yamashita F; Hashida M
    J Control Release; 2011 Jan; 149(1):42-50. PubMed ID: 20035809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation.
    Matsushita H; Morishita R; Nata T; Aoki M; Nakagami H; Taniyama Y; Yamamoto K; Higaki J; Yasufumi K; Ogihara T
    Circ Res; 2000 May; 86(9):974-81. PubMed ID: 10807870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of NFkappaB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line.
    Gill JS; Zhu X; Moore MJ; Lu L; Yaszemski MJ; Windebank AJ
    Biomaterials; 2002 Jul; 23(13):2773-81. PubMed ID: 12059028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides.
    Xu MQ; Suo YP; Gong JP; Zhang MM; Yan LN
    World J Gastroenterol; 2004 Aug; 10(16):2361-8. PubMed ID: 15285020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo.
    Wang T; Li QH; Hao GP; Zhai J
    Asian Pac J Cancer Prev; 2010; 11(1):193-200. PubMed ID: 20593956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of ribbon-type decoy oligodeoxynucleotide against nuclear factor κB and ets prevents abdominal aortic aneurysm in rat model.
    Miyake T; Aoki M; Osako MK; Shimamura M; Nakagami H; Morishita R
    Mol Ther; 2011 Jan; 19(1):181-7. PubMed ID: 20877343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of intracranial aneurysms by simultaneous inhibition of nuclear factor-κB and Ets with chimeric decoy oligodeoxynucleotide treatment.
    Aoki T; Kataoka H; Nishimura M; Ishibashi R; Morishita R; Miyamoto S
    Neurosurgery; 2012 Jun; 70(6):1534-43; discussion 1543. PubMed ID: 22186838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model.
    Miyake T; Aoki M; Masaki H; Kawasaki T; Oishi M; Kataoka K; Ogihara T; Kaneda Y; Morishita R
    Circ Res; 2007 Nov; 101(11):1175-84. PubMed ID: 17885220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of NFkappaB inhibitor for arthritis].
    Tomita T; Kunugiza Y; Nomura K; Morimoto D; Kuroda S; Yoshikawa H
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):71-6. PubMed ID: 19404004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts.
    Azuma H; Tomita N; Kaneda Y; Koike H; Ogihara T; Katsuoka Y; Morishita R
    Gene Ther; 2003 Mar; 10(5):415-25. PubMed ID: 12601396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides.
    Fichtner-Feigl S; Fuss IJ; Preiss JC; Strober W; Kitani A
    J Clin Invest; 2005 Nov; 115(11):3057-71. PubMed ID: 16239967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line.
    Fang Y; Sun H; Zhai J; Zhang Y; Yi S; Hao G; Wang T
    Asian Pac J Cancer Prev; 2011; 12(10):2721-6. PubMed ID: 22320981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor-kappaB decoy oligodeoxynucleotides attenuates ischemia/reperfusion injury in rat liver graft.
    Xu MQ; Shuai XR; Yan ML; Zhang MM; Yan LN
    World J Gastroenterol; 2005 Nov; 11(44):6960-7. PubMed ID: 16437600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa.
    Gambari R; Borgatti M; Bezzerri V; Nicolis E; Lampronti I; Dechecchi MC; Mancini I; Tamanini A; Cabrini G
    Biochem Pharmacol; 2010 Dec; 80(12):1887-94. PubMed ID: 20615393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.